Contrasting effects of μ opioid receptor and δ opioid receptor deletion upon the behavioral and neurochemical effects of cocaine

Neuroscience

Volumn 127, Issue 2, 2004, Pages 497-503

  Chefer, V I ^a   Kieffer, B L ^b   Shippenberg, T S ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b INSTITUT DE GÉNÉTIQUE ET DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

opioid receptors; and opioid receptors; aCSF; analysis of variance; ANOVA; area under the curve; artificial cerebrospinal fluid; AUC; cocaine; conventional microdialysis; DA; dopamine; DOR; EDTA; ethylenediaminetetra acetate; knockout mice; KO

Indexed keywords

COCAINE; DELTA OPIATE RECEPTOR; DOPAMINE; MU OPIATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; CONTROLLED STUDY; GENOTYPE; KNOCKOUT MOUSE; LOCOMOTION; MALE; MICRODIALYSIS; MOUSE; NEUROCHEMISTRY; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; WILD TYPE;

ANIMALS; BRAIN; BRAIN CHEMISTRY; COCAINE; COCAINE-RELATED DISORDERS; DOPAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR FLUID; GENOTYPE; MICE; MICE, KNOCKOUT; MICRODIALYSIS; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; OPIOID PEPTIDES; RECEPTORS, OPIOID, DELTA; RECEPTORS, OPIOID, MU;

EID: 3242688885     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2004.05.021     Document Type: Article

References (35)

1. Akil H., Meng F., Mansour A., Thompson R., Xie G.X., Watson S. Cloning and characterization of multiple opioid receptors. NIDA Res Monogr. 161:1996;127-140
2. Akil H., Owens C., Gutstein H., Taylor L., Curran E., Watson S. Endogenous opioids Overview and current issues. Drug Alcohol Depend. 51:1998;127-140
3. Becker A., Grecksch G., Kraus J., Loh H.H., Schroeder H., Hollt V. Rewarding effects of ethanol and cocaine in mu opioid receptor-deficient mice. Naunyn Schmiedebergs Arch Pharmacol. 365:2002;296-302
4. Chefer V.I., Kieffer B.L., Shippenberg T.S. Basal and morphine-evoked dopaminergic neurotransmission in the nucleus accumbens of MOR- and DOR-knockout mice. Eur J Neurosci. 18:2003;1915-1922
5. Dauge V., Kalivas P.W., Duffy T., Roques B.P. Effect of inhibiting enkephalin catabolism in the VTA on motor activity and extracellular dopamine. Brain Res. 599:1992;209-214
6. De Vries T.J., Babovic-Vuksanovic D., Elmer G., Shippenberg T.S. Lack of involvement of delta-opioid receptors in mediating the rewarding effects of cocaine. Psychopharmacology (Berl). 120:1995;442-448
7. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA. 85:1988;5274-5278
8. Dourmap N., Clero E., Costentin J. Involvement of cholinergic neurons in the release of dopamine elicited by stimulation of mu-opioid receptors in striatum. Brain Res. 749:1997;295-300
9. Dourmap N., Costentin J. Involvement of glutamate receptors in the striatal enkephalin-induced dopamine release. Eur J Pharmacol. 253:1994;R9-11
10. Dourmap N., Michael-Titus A., Costentin J. Differential effect of intrastriatal kainic acid on the modulation of dopamine release by mu- and delta-opioid peptides A microdialysis study. J Neurochem. 58:1992;709-713
11. Filliol D., Ghozland S., Chluba J., Martin M., Matthes H.W., Simonin F., Befort K., Gaveriaux-Ruff C., Dierich A., LeMeur M., Valverde O., Maldonado R., Kieffer B.L. Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet. 25:2000;195-200
12. Gibaldi M., Perier D. The trapezoid rule. Gibaldi M., Perier D. Pharmacokinetics. 1975;293-296 Marcel Dekker, New York
13. Heidbreder C., Goldberg S.R., Shippenberg T.S. Inhibition of cocaine-induced sensitization by the delta-opioid receptor antagonist naltrindole. Eur J Pharmacol. 243:1993;123-127
14. Houdi A.A., Bardo M.T., Van Loon G.R. Opioid mediation of cocaine-induced hyperactivity and reinforcement. Brain Res. 497:1989;195-198
15. Jones D.N., Bowen W.D., Portoghese P.S., Holtzman S.G. Delta-opioid receptor antagonists attenuate motor activity induced by amphetamine but not cocaine. Eur J Pharmacol. 249:1993;167-177
16. Kalivas P.W., Widerlov E., Stanley D., Breese G., Prange A.J. Jr. Enkephalin action on the mesolimbic system A dopamine-dependent and a dopamine-independent increase in locomotor activity. J Pharmacol Exp Ther. 227:1983;229-237
17. Kieffer B.L. Opioids First lessons from knockout mice. Trends Pharmacol Sci. 20:1999;19-26
18. Kieffer B.L., Gaveriaux-Ruff C. Exploring the opioid system by gene knockout. Prog Neurobiol. 66:2002;285-306
19. Matthes H.W., Maldonado R., Simonin F., Valverde O., Slowe S., Kitchen I., Befort K., Dierich A., Le Meur M., Dolle P., Tzavara E., Hanoune J., Roques B.P., Kieffer B.L. Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the mu-opioid-receptor gene. Nature. 383:1996;819-823
20. Meredith G.E. The synaptic framework for chemical signaling in nucleus accumbens. Ann NY Acad Sci. 877:1999;140-156
21. Rademacher D.J., Steinpreis R.E. Effects of the selective mu(1)-opioid receptor antagonist, naloxonazine, on cocaine-induced conditioned place preference and locomotor behavior in rats. Neurosci Lett. 332:2002;159-162
22. Reid L.D., Glick S.D., Menkens K.A., French E.D., Bilsky E.J., Porreca F. Cocaine self-administration and naltrindole, a delta-selective opioid antagonist. Neuroreport. 6:1995;1409-1412
23. Ritz M.C., Kuhar M.J. Psychostimulant drugs and a dopamine hypothesis regarding addiction Update on recent research. Biochem Soc Symp. 59:1993;51-64
24. Schad C.A., Justice J.B.J., Holtzman S.G. Differential effects of delta- and mu-opioid receptor antagonists on the amphetamine-induced increase in extracellular dopamine in striatum and nucleus accumbens. J Neurochem. 67:1996;2292-2299
25. 35S]GTPgammaS binding in rat brain. Synapse. 47:2003;26-32
26. Shippenberg T.S., Chefer V.I. Opioid modulation of psychomotor stimulant effects. Maldonado R. Molecular biology of drug addiction. 2003;107-132 Humana Press Inc, Totowa, NJ
27. Shippenberg T.S., Heidbreder C. The delta-opioid receptor antagonist naltrindole prevents sensitization to the conditioned rewarding effects of cocaine. Eur J Pharmacol. 280:1995;55-61
28. Slotnick B.M., Leonard C.M. A stereotaxic atlas of the albino mouse forebrain. 1975;US Department of Health, Education and Welfare, Rockville, MD
29. Spanagel R., Herz A., Shippenberg T.S. Identification of the opioid receptor types mediating beta-endorphin- induced alterations in dopamine release in the nucleus accumbens. Eur J Pharmacol. 190:1990;177-184
30. Spanagel R., Herz A., Shippenberg T.S. The effects of opioid peptides on dopamine release in the nucleus accumbens An in vivo microdialysis study. J Neurochem. 55:1990;1734-1740
31. Spanagel R., Herz A., Shippenberg T.S. Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci USA. 89:1992;2046-2050
32. Suzuki T., Mori T., Tsuji M., Misawa M., Nagase H. The role of delta-opioid receptor subtypes in cocaine- and methamphetamine-induced place preferences. Life Sci. 55:1994;L339-L344
33. Tao R., Auerbach S.B. Opioid receptor subtypes differentially modulate serotonin efflux in the rat central nervous system. J Pharmacol Exp Ther. 303:2002;549-556
34. Unterwald E.M. Regulation of opioid receptors by cocaine. Ann NY Acad Sci. 937:2001;74-92
35. Yoo J.H., Yang E.M., Lee S.Y., Loh H.H., Ho I.K., Jang C.G. Differential effects of morphine and cocaine on locomotor activity and sensitization in mu-opioid receptor knockout mice. Neurosci Lett. 344:2003;37-40